Press releases

You'll find below all the official Press Releases from Ceva.

16 May 2013

2013 reprodAction Scientific Meeting - April 16-17th >

“Management and reproduction of dairy heifers”

1 May 2013

Ceva uses creative thinking in new approach to innovation in Industrial equity >

Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value if you cannot produce them efficiently, on time and to the highest quality standards. As a result, Ceva recently organized its first industrial innovation day – entitled Together, Creative Innovation,...

28 April 2013

Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >

Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.

14 April 2013

Ceva enter global partnership to improve Cat Care >

Partnership between International Cat Care and Ceva will work closely to promote the benefits of cat ownership

11 April 2013

New Technology Vaccine Symposium - Miami >

Ceva shares global field experiences through New Technology Vaccine Symposium held in the US. Innovation in the hatchery will drive productivity gains

4 April 2013

Ceva Welfare Awards – Winners announcement >

2nd Annual Ceva Animal Welfare Awards, celebrating the contributions to the prevention and reduction of animal welfare problems in the UK and abroad.

6 February 2013

Ceva records double digit growth for 3rd. successive year >

14% growth pushes sales beyond 600 M€ for first time

24 January 2013

Ceva presents a complete range of vector vaccines at IPE 2013 >

Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.

18 November 2012

Ceva announces scientific breakthrough with the launch of Vectormune® AI >

Vectormune® AI a new generation vaccine for the control of Avian Influenza.

29 October 2012

AXA Private Equity provides additional financing to support the development of Ceva >

AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.

Back to top